{
     "PMID": "25449889",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150804",
     "LR": "20141209",
     "IS": "1872-6240 (Electronic) 0006-8993 (Linking)",
     "VI": "1594",
     "DP": "2015 Jan 12",
     "TI": "SUN11602-induced hyperexpression of calbindin D-28k is pivotal for the survival of hippocampal neurons under neurotoxic conditions.",
     "PG": "71-81",
     "LID": "10.1016/j.brainres.2014.10.066 [doi] S0006-8993(14)01488-7 [pii]",
     "AB": "Basic fibroblast growth factor (FGF-2/bFGF) possesses neuroprotective activity and promotes cell proliferation. In this study, the novel synthetic compound 4-({4-[[(4-amino-2,3,5,6-tetramethylanilino)acetyl](methyl)amino]-1-piperidinyl}m ethyl)benzamide (SUN11602) exhibited neuroprotective activities similar to those of FGF-2 without promoting cell proliferation. In primary cultures of hippocampal neurons, stimulation with SUN11602 or FGF-2 increased calbindin D-28k (CalB) gene expression and prevented glutamate-induced neuronal death. These effects were abolished by pretreatment with PD166866 (FGF receptor 1 [FGFR1] tyrosine kinase-specific inhibitor). This indicated that FGFR1 activation and increased CalB expression were involved in SUN11602-mediated neuroprotection. However, receptor-binding assays revealed that unlike FGF-2, SUN11602 did not alter the binding of (125)I-labeled FGF-2 to FGFR1. To investigate the possible proliferative activity of SUN11602, we utilized BHK21 and SKN cells expressing endogenous FGFR1. FGF-2 promoted cell proliferation whereas SUN11602 did not. In in vivo studies, wild-type (WT) and CalB-deficient (CalB(-/-)) mice were injected with aggregated Abeta1-40 and ibotenate (NMDA receptor agonist) to severely damage the hippocampal tissue. Treatment with SUN11602 (orally) or FGF-2 (intraparenchymally) at the midpoint of Abeta1-40 and ibotenate injections prevented the hippocampal damage in WT mice, however this effect was abolished in CalB(-/-) mice. Thus, SUN11602 exerted protective effects on hippocampal neurons through activation of FGFR1 and increased CalB expression. Moreover, the neuroprotective effects of SUN11602 depended upon the various biological activities of FGF-2.",
     "CI": [
          "Copyright (c) 2014 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Murayama, Norihito",
          "Noshita, Takafumi",
          "Ogino, Ryoko",
          "Masuda, Toyofumi",
          "Kadoshima, Taisuke",
          "Oka, Tetsushi",
          "Ueno, Nobuhiro",
          "Takemoto, Naohiro",
          "Toba, Tetsuya",
          "Ueno, Shinya",
          "Schulze, Wiebke",
          "Igawa, Yoshiyuki",
          "Morita, Yasuhiro",
          "Inoue, Teruyoshi"
     ],
     "AU": [
          "Murayama N",
          "Noshita T",
          "Ogino R",
          "Masuda T",
          "Kadoshima T",
          "Oka T",
          "Ueno N",
          "Takemoto N",
          "Toba T",
          "Ueno S",
          "Schulze W",
          "Igawa Y",
          "Morita Y",
          "Inoue T"
     ],
     "AD": "Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Electronic address: murayama.norihito.rk@asubio.co.jp. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Laboratory of Physiology and Morphology, Faculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan. Asubio Pharma Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20141106",
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0",
          "(4-((4-(((4-amino-2,3,5,6-tetramethylanilino)acetyl)(methyl)amino)-1-piperidinyl)",
          "methyl)benzamide)",
          "0 (Benzamides)",
          "0 (Calb1 protein, mouse)",
          "0 (Calbindin 1)",
          "0 (Neuroprotective Agents)",
          "0 (Phenylenediamines)",
          "103107-01-3 (Fibroblast Growth Factor 2)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Benzamides/*pharmacology",
          "Calbindin 1/*biosynthesis",
          "Cell Survival/drug effects",
          "Fibroblast Growth Factor 2/metabolism/pharmacology",
          "Hippocampus/drug effects/metabolism",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Knockout",
          "Neurons/*drug effects/metabolism",
          "Neuroprotective Agents/*pharmacology",
          "Phenylenediamines/*pharmacology",
          "Polymerase Chain Reaction",
          "Rats",
          "Rats, Wistar"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Calbindin D-28k",
          "Calcium homeostasis",
          "Cell proliferation",
          "FGF-2",
          "Neuroprotection",
          "SUN11602"
     ],
     "EDAT": "2014/12/03 06:00",
     "MHDA": "2015/08/05 06:00",
     "CRDT": [
          "2014/12/03 06:00"
     ],
     "PHST": [
          "2013/06/14 00:00 [received]",
          "2014/09/12 00:00 [revised]",
          "2014/10/29 00:00 [accepted]",
          "2014/12/03 06:00 [entrez]",
          "2014/12/03 06:00 [pubmed]",
          "2015/08/05 06:00 [medline]"
     ],
     "AID": [
          "S0006-8993(14)01488-7 [pii]",
          "10.1016/j.brainres.2014.10.066 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2015 Jan 12;1594:71-81. doi: 10.1016/j.brainres.2014.10.066. Epub 2014 Nov 6.",
     "term": "hippocampus"
}